Telmisartan and cardioprotection

Philippe R Akhrass, Samy I McFarlaneState University of New York, Downstate Medical Center, Brooklyn, NY, USAAbstract: Cardiovascular risk reduction has been the target of several large clinical trials in the last decade. As the activation of the renin-angiotensin-aldosterone system (RAAS) plays a c...

Full description

Bibliographic Details
Main Author: McFarlane S
Format: Article
Language:English
Published: Dove Medical Press 2011-11-01
Series:Vascular Health and Risk Management
Subjects:
Online Access:https://www.dovepress.com/telmisartan-and-cardioprotection-peer-reviewed-article-VHRM